Elena Ridloff CFA — Vice President of Investor Relations at Alexion Pharmaceuticals

Executive Bio

Ms. Elena Ridloff, CFA, has been Vice President of Investor Relations at Alexion Pharmaceuticals, Inc since January 2016. Ms. Ridloff served as an Executive Director of Investor Relations at Alexion Pharmaceuticals, Inc. since April 2014 until January 2016. Ms. Ridloff served as a Research Analyst for Paramount BioCapital Asset Management, Inc. since July 2001. Paramount BioCapital Asset Management, Inc. is an affiliate of Paramount BioCapital, Inc., and serves as the general partner or investment manager to several privately held investment entities that focus on the biotechnology industry. Her primary responsibilities include the thorough research and analysis of financial, medical and scientific merits of private and public biomedical and pharmaceutical companies. Ms. Ridloff serves as a Director of Lantibio, Inc. She holds a Bachelors of Arts from the University of Pennsylvania.

Executive Team Culture Ratings from Alexion Pharmaceuticals Employees

BOTTOM

20%

Alexion Pharmaceuticals' Executive Team scores in the Bottom 20%
of similar sized companies on Comparably

See Detailed Executive Team Ratings

Who ranks the Executive Team the highest?

Gender - Male 65/100

Experience - Over 10 Years 58/100

Department - HR 50/100

Who ranks the Executive Team the lowest?

Gender - Female 28/100

Ethnicity - Other 33/100

Ethnicity - Caucasian 50/100

Alexion Pharmaceuticals' Executive Team at a Glance

Based on 19 ratings, Alexion Pharmaceuticals' employees are less satisfied with their Executive Team and give them a “D” or 53/100. On average, Men provided higher ratings for their Executive Team compared to Women.

Alexion Pharmaceuticals' Executive Team ranks in the Bottom 15% of other companies in New York and Bottom 20% of other companies on Comparably that also have 1,001-5,000 Employees.

Rate your company